• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a novel therapy for liver failure, using amniotic epithelial cells

Research Project

Project/Area Number 18K16341
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionUniversity of Tsukuba

Principal Investigator

Takahashi Kazuhiro  筑波大学, 医学医療系, 講師 (80794528)

Project Period (FY) 2018-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords羊膜上皮細胞 / 肝再生 / 肝細胞 / 肝芽細胞 / IPS細胞 / 胚体内胚葉 / Albumin / 内胚葉系細胞 / 分化誘導 / 内胚葉化 / 肝不全 / 劇症肝炎
Outline of Final Research Achievements

In vitro study, we assessed if human amnion epithelial cells (hAEC) derived from ectoderm could differentiate into human hepatocyte, using IPS protocol or previous AEC protocols used for mice AEC. But, we could not find any evidence of hAEC to differentiate into human hepatocytes or definite endoderm-AEC. On the other hand, using natural product, Isoharmnetin, there was some evidence that hAEC could differentiate into human hepatoblasts. We consider Isoharmenetin as a key element of hAEC for hepatocyte differentiation.
On the other hand, in vivo study, we could not find any evidence of hAEC for human hepatocyte differentiation.

Academic Significance and Societal Importance of the Research Achievements

廃棄処分される胎盤から分離される羊膜上皮細胞を用いて、細胞実験や動物実験で肝細胞に分化させることができるかどうかを検証した。Natural productであるIsoharmnetinによる分化誘導により羊膜上皮細胞が肝細胞の前駆細胞である肝芽細胞への分化を示唆する結果を得られた。今後、条件設定を見直すことで、分化できる肝芽細胞を増やすことができ、さらに肝細胞に分化させることができる可能性が示唆された。

Report

(3 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report

URL: 

Published: 2018-04-23   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi